Burnett A F, Lossef S V, Barth K H, Grendys E C, Johnson J C, Barter J F, Barnes W A
Department of Obstetrics and Gynecology, Georgetown University Medical Center, Washington, D.C. 20007.
Gynecol Oncol. 1994 Jan;52(1):69-73. doi: 10.1006/gyno.1994.1013.
Groshong central line indwelling catheters are extensively used in gynecologic oncology patients for administration of chemotherapy, intravenous fluids, and pain medications. They are easy to maintain and have a good safety record. We report on the placement of these central venous catheters under direct fluoroscopic visualization as a method which is safe, inexpensive, and efficacious in high-risk patients. Fluoroscopic visualization during insertion provides several advantages: visualization of bony landmarks, placement of the guidewire into the subclavian vein and superior vena cava under direct visualization, and confirmation of appropriate distal placement of the Groshong catheter. Patient advantages include the following: (1) avoidance of unnecessary punctures to access the subclavian vein; (2) verification of guidewire placement to avoid cephalic placement; (3) passage of the guidewire only as far as the right atrium to avoid potential dysrrhythmias secondary to right ventricular irritation; and (4) a savings of approximately 60% over insertion in the general operating room. Thirty patients had placement under fluoroscopic visualization in the angiography suite of Georgetown University Hospital. The average age of the patients was 58 years (42-78). Sixteen patients had ovarian cancer, 6 had endometrial cancer, 5 had cervical cancer, and 3 had other gynecologic malignancies. Fifteen patients had catheters placed for chemotherapy, 14 for hydration, and 1 for pain control. Ten patients had had previous central venous catheters: 6 had been removed for infection, 2 for thrombus, 1 for completion of chemotherapy, and 1 for catheter kinkage. All 10 with previous catheters had successful placement of catheters in the angiography suite. Complications from insertion were minimal with one asymptomatic pneumothorax and one proximal port in an extravascular position. We present the technique of fluoroscopic insertion of Groshong catheters which is an effective method of placement in high-risk patients.
格罗雄中心静脉留置导管广泛应用于妇科肿瘤患者,用于化疗、静脉输液和止痛药物的给药。它们易于维护,且安全性良好。我们报告在直接透视引导下放置这些中心静脉导管,这是一种对高危患者安全、廉价且有效的方法。插入过程中的透视引导具有多个优点:可看到骨性标志,在直视下将导丝置入锁骨下静脉和上腔静脉,并确认格罗雄导管远端放置位置合适。对患者的好处包括:(1)避免不必要的穿刺以进入锁骨下静脉;(2)核实导丝放置位置以避免进入头静脉;(3)导丝仅插入至右心房以避免因刺激右心室继发潜在的心律失常;(4)与在普通手术室插入相比,节省约60%的费用。30例患者在乔治敦大学医院血管造影室的透视引导下进行了导管放置。患者的平均年龄为58岁(42 - 78岁)。16例患者患有卵巢癌,6例患有子宫内膜癌,5例患有宫颈癌,3例患有其他妇科恶性肿瘤。15例患者放置导管用于化疗,14例用于补液,1例用于控制疼痛。10例患者曾有过中心静脉导管:6例因感染被拔除;2例因血栓被拔除;1例因化疗结束被拔除;1例因导管扭结被拔除。所有这10例曾有过导管的患者在血管造影室均成功放置了导管。插入的并发症极少,仅1例无症状气胸和1例近端端口位于血管外。我们介绍了格罗雄导管透视插入技术——这是一种对高危患者有效的放置方法